US Patent:
20150105373, Apr 16, 2015
Inventors:
- Osaka-shi, Osaka, JP
Shinji Nakamura - Kanagawa, JP
Tomoko Ashizawa - New York NY, US
Shigekazu Sasaki - Kanagawa, JP
Takahiko Taniguchi - Kanagawa, JP
Izumi Nomura - Kanagawa, JP
Masanori Kawasaki - New York NY, US
International Classification:
C07D 471/04
C07D 519/00
US Classification:
51421021, 544350, 514249, 544295
Abstract:
The present invention provides a compound having a PDE2A selective inhibitory action, which is useful as an agent for the prophylaxis or treatment of schizophrenia, Alzheimer's disease and the like.The present invention is a compound represented by the formula (1):wherein each symbol is as described in the specification, or a salt thereof.